T

Tango Therapeutics
D

TNGX

3.84700
USD
0.05
(1.24%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-3
Market Cap
413,236,346
OverviewSignalsIdeasNews
Related Instruments
    B
    BLDP
    0.01500
    (1.18%)
    1.28500 USD
    C
    CSIQ
    -0.770
    (-6.54%)
    11.000 USD
    E
    ENPH
    -4.050
    (-6.37%)
    59.510 USD
    F
    FCEL
    -0.86000
    (-12.29%)
    6.14000 USD
    J
    JKS
    -0.415
    (-1.95%)
    20.920 USD
    P
    PLUG
    -0.10500
    (-5.33%)
    1.86500 USD
    R
    RUN
    -1.06000
    (-9.70%)
    9.87000 USD
    S
    SEDG
    -2.185
    (-17.04%)
    10.640 USD
    S
    SPWR
    0
    (0%)
    0.000000 USD
    More
News

Title: Tango Therapeutics

Sector: Healthcare
Industry: Biotechnology
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.